Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00615_DB00661_nanopub.RAUn-DN-15OUsFcfl1F5nE1YOljU4y3lPYbO-kBuTNSS0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00615_DB00661 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00615_DB00661 label "DDI between Rifabutin and Verapamil - Rifabutin, a CYP3A4 inducer, may decrease the serum concentration of Verapamil by increasing its metabolism (particularly in the intestinal mucosa) and decreasing its absorption. Monitor for changes in the therapeutic/adverse effects of Verapamil if Rifabutin is initiated, discontinued or dose changed. [drugbank_resource:DB00615_DB00661]" assertion.
- drugbank_resource:DB00615_DB00661 identifier "drugbank_resource:DB00615_DB00661" assertion.
- drugbank_resource:DB00615_DB00661 title "DDI between Rifabutin and Verapamil - Rifabutin, a CYP3A4 inducer, may decrease the serum concentration of Verapamil by increasing its metabolism (particularly in the intestinal mucosa) and decreasing its absorption. Monitor for changes in the therapeutic/adverse effects of Verapamil if Rifabutin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB00661 assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB00661 assertion.